In general, this variant in the MIR618 gene has been associated with the regulation of miR-618 expression and has implications for susceptibility and progression of various diseases, including breast cancer, colorectal carcinoma, and metastatic colon cancer [80,81,82,83]. This evidence concerns the gene MIR618 and breast cancer.